Vaxil Bio Ltd.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (5)
Compared with Healthcare companies in Canada.
P/E ratio
0.9Investors pay 0.9 for every 1 of Vaxil Bio Ltd.'s yearly profit, lower than 93% of Healthcare companies in Canada.
P/B ratio
0.43The share price is 0.43 times Vaxil Bio Ltd.'s book value per share, lower than 90% of Healthcare companies in Canada.
Market cap
C$1 MThe total market value of all of Vaxil Bio Ltd.'s shares at today's price (share price × number of shares), smaller than almost all Healthcare companies in Canada. PosiCap size class: Nano Cap.
Return on equity (ROE)
39.9%Vaxil Bio Ltd. earned 39.9% on its shareholders' money over the last year, higher than 98% of Healthcare companies in Canada.
Dividend yield
NoneVaxil Bio Ltd. does not currently pay a dividend.
Questions
What is Vaxil Bio Ltd.'s P/E ratio?
Investors pay 0.9 for every 1 of Vaxil Bio Ltd.'s yearly profit, lower than 93% of Healthcare companies in Canada.
What is Vaxil Bio Ltd.'s return on equity?
Vaxil Bio Ltd. earned 39.9% on its shareholders' money over the last year, higher than 98% of Healthcare companies in Canada.
Does Vaxil Bio Ltd. pay a dividend?
No. Vaxil Bio Ltd. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.